Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Equity (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Return on Equity for 4 consecutive years, with 0.75% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 34.0% to 0.75% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.75%, a 34.0% decrease, with the full-year FY2024 number at 0.74%, down 21.0% from a year prior.
  • Return on Equity was 0.75% for Q3 2025 at Centessa Pharmaceuticals, down from 0.63% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.41% in Q3 2024 to a low of 0.75% in Q3 2025.
  • A 4-year average of 0.6% and a median of 0.61% in 2022 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: grew 18bps in 2024, then plummeted -34bps in 2025.
  • Centessa Pharmaceuticals' Return on Equity stood at 0.61% in 2022, then grew by 0bps to 0.61% in 2023, then rose by 14bps to 0.52% in 2024, then crashed by -43bps to 0.75% in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Return on Equity are 0.75% (Q3 2025), 0.63% (Q2 2025), and 0.57% (Q1 2025).